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Background: The genetic integrity of living organisms is 
maintained by a complex network of DNA repair pathways. 
Nucleotide excision repair (NER) is a versatile process that 
excises bulky base modifications from DNA. To study the 
substrate range of this system, we constructed bulky 
deoxyribose adducts that do not affect the chemistry of the 
corresponding bases.These novel adducts were incorporated 
into double-stranded DNA in a site-specific manner and the 
repair of the modified sites was investigated. 
Results: Using restriction enzymes as a probe for DNA 
modification, we confirmed that the resulting substrates 
contained the bulky deoxyribose adducts at the expected 
position. DNA containing these unique adducts did not 
stimulate DNA repair synthesis when mixed with an 
NER-competent human cell extract. Inefficient repair of 
deoxyribose adducts was confirmed by monitoring the 
release of single-stranded oligonucleotides during the exci- 
sion reaction that precedes DNA repair synthesis. As a 
control, the same human cell extract was able to process a 
base adduct of comparable size. 
Conclusions: Our results indicate that modification of 
DNA bases rather than disruption of the sugar-phosphate 
backbone is an important determinant for damage recog- 
nition by the human NER system. Specific positions in 
DNA may thus be modified without eliciting NER 
responses.This observation suggests new strategies for anti- 
cancer drug design to generate DNA modifications that are 
refractory to repair processes. 
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Introduction 
DNA repair mechanisms are essential for the develop- 
ment and maintenance of life. A few specific DNA 
lesions may be eliminated by direct reversal, but most 
types of DNA damage are removed by excision repair 
mechanisms [l]. In particular, bulky base adducts are 
processed in prokaryotic and eukaryotic cells by a geneti- 
cally and biochemically complex pathway, referred to as 
nucleotide excision repair (NER) [2-41. This system cata- 
lyzes cleavage of the damaged DNA strand on either side 
of the lesion followed by excision of a single-stranded 
oligonucleotide containing the lesion. The correct 
nucleotide sequence is then reestablished by DNA repair 
synthesis and DNA ligation. The human NER system 
removes damage from DNA by cleaving the 22nd phos- 
phodiester bond 5’ and the 6th phosphodiester bond 3’ 
to the lesion. This dual incision pattern generates single- 
stranded excision products that are 29 residues in length 
151. In vitro repair reactions performed with human cell 
extracts have confirmed that repair patches induced by 
this pathway extend over a segment of -30 nucleotides 
around the lesion [5,6]. 
Most eukaryotic cells use NER to remove the principal 
forms of DNA damage induced by ultraviolet (W) irradi- 
ation [2-4,7]. NER is a highly versatile pathway, however, 
and has been implicated in the excision of virtually any 
kind of bulky DNA adduct, including those induced 
by the antitumor drug cisplatin, cic-diamminedichloro- 
platinum(II), or the carcinogen N-acetoxy-2-acetylamino- 
fluorene [6,8-lo]. A common feature of these and other 
covalent DNA adducts identified as substrates for eukary- 
otic NER is the modification of the DNA bases.We there- 
fore decided to test whether DNA adducts located on the 
deoxyribose moiety may also induce an NER response. 
Here we report the construction of double-stranded DNA 
containing single and site-specific deoxyribose adducts. 
These novel, bulky modifications were obtained by linking 
a selenophenyl or a pivaloyl group to the C4’ position of 
deoxyribose without affecting the chemistry of the corre- 
sponding bases (Fig. 1). When incubated with an NER- 
proficient human cell extract, DNA containing the 
selenophenyl or the pivaloyl substitution could not stimu- 
late DNA repair synthesis. Also, the two deoxyribose 
adducts failed to induce the dual DNA incision pattern 
that is characteristic of human NER. In parallel control 
reactions, a bulky guanine adduct formed by N-acetoxy- 
2-acetylaminofluorene stimulated both DNA excision and 
subsequent DNA repair synthesis. 
Results 
Preparation of double-stranded Ml 3 DNA containing a 
site-specific modification 
The procedure for the construction of closed circular 
DNA, containing uniquely located selenophenyl- or 
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Fig. 1. Structure of the bulky selenophenyl (top) and pivaloyl 
(bottom) adducts. These novel bulky adducts were covalently 
bound to the C4’ position of a single deoxyribose residue in 
double-stranded DNA. The chemical structure of the correspond- 
ing adenine (A) or thymine (T) base remains unaffected by these 
deoxyribose modifications. 
pivaloyl-deoxyribose adducts, is described in detail in the 
Materials and methods section. Briefly, the approach 
taken was to ligate a complementary synthetic oligo- 
nucleotide, with the selenophenyl or the pivaloyl adduct 
located in a central position, into a double-stranded 
Ml 3-DNA intermediate containing a single-stranded 
gap (Fig. 2).The ligation products were purified as cova- 
lently closed circular duplexes by CsCl gradient centrifu- 
gation. Ml3 DNA with a site-specifically placed 
acetylaminofluorene (AAF) modification was synthesized 
by ligating into the gapped intermediate an oligo- 
nucleotide containing a single AAF-guanine adduct. A 
parallel construct with unmodified oligonucleotides was 
synthesized and isolated using identical methods. 
Restriction analysis of covalently closed circular DNA 
The site-specific modifications were positioned in the 
unique BstBI recognition sequence (5’-TTCGAA-3’) 
contained in the M13-DNA derivative used in this study 
(Fig. 3). We therefore tested the correct location of the 
AAF, selenophenyl, or pivaloyl adduct by restriction 
analysis of CsCl-purified substrate with BstBI. Circular, 
double-stranded Ml3 DNA, constructed with the un- 
modified oligonucleotide, was linearized by digestion 
with BstBI (Fig. 3; lane 4). In contrast, AAF-modified 
Ml3 DNA was resistant to digestion by this enzyme 
(Fig. 3; lane 6). Similarly, BstBI could not cleave seleno- 
phenyl-modified (Fig. 3; lane 8) or pivaloyl-modified 
DNA (data not shown).To rule out non-specific enzyme 
inhibition, we also determined that all four M13-DNA 
derivatives were efficiently cleaved by P1’stI (which recog- 
nizes a unique site in Ml3 DNA proximal to the adduct) 
and AlwNI (which recognizes a unique site at a distance 
of -2000 base pairs (bp) from the adduct), yielding linear 
DNA. The observation that BstBI cannot cleave the 
modified substrates established that the purified material 
consisted of homogenous products containing one 
selenophenyl, pivaloyl, or AAF adduct per Ml3 DNA 
molecule at the expected position. 
DNA repair synthesis 
The purified covalently closed circular M13-DNA mole- 
cules were used to determine whether DNA repair com- 
ponents in an NER-proficient human cell extract [6,8] 
could recognize the DNA adducts. DNA substrates were 
incubated with soluble HeLa-cell extract in the presence 
of ATP and all four deoxynucleoside triphosphates, with 
dCTP radiolabelled (Fig. 4). The HeLa-cell extract con- 
tains all factors that are required for damage-specific inci- 
sion of DNA, excision of the damaged segment, and 
DNA repair synthesis [6,&l 11. Ml3 DNA was recovered 
after reaction with the extract for 3 h and was digested 
with AvuII, SlnaI, and PstI. This treatment results in the 
formation of three double-stranded fragments of 37,330, 
and 6920 bp (Fig. 4). Previous studies established that in 
vitro repair of bulky modifications, such as the AAF 
adduct, is strictly dependent on the NER system, which 
in human cell extracts induces repair patches of -30 
nucleotides around the lesion [5,6]. In our study, quantifi- 
cation of these NER patches is facilitated by the presence 
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Fig. 2. Schematic representation of the procedure used to con- 
struct Ml 3 DNA containing site-specific adducts. The method is 
based on the synthesis of a gapped Ml 3-DNA intermediate (see 
Materials and methods for details). A complementary 19-mer 
(5’-ACCACCCTTCGAACCACAC-3’) is ligated into this gapped 
structure to obtain covalently closed circular Ml3 DNA. The 
19-mer was either undamaged, or contained an AAF base adduct 
at position Cl 1, a selenophenyl substitution on the deoxyribose 
moiety at position Al 2, or a pivaloyl-deoxyribose substitution at 
position T9. All three modifications fall into the unique BstE%l 
restriction endonuclease cleavage site (5’.TTCCAA-3’) of the 
Ml 3-DNA construct. 
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Fig. 3. Modification of the BstBl restriction endonuclease recogni- 
tion sequence in Ml3 DNA with an AAF base adduct or a 
selenophenyl deoxyribose adduct prevents digestion with BstBI. 
The products of restriction enzyme analysis of Ml 3-DNA deriva- 
tives are shown. DNA was subjected to digestion with BstBI and 
analyzed by agarose gel electrophoresis. The positions of cova- 
lently closed circular (ccc), linear, and nicked Ml3 DNA are indi- 
cated. The AAF adduct at position Cl 1 completely inhibited 
digestion by BsfBl (lane 6). Digestion of Ml3 DNA was also 
blocked by the site-specific selenophenyl adduct (SePh) situated 
on the deoxyribose residue of Al2 (lane 8). Lane 1: unmodified 
Ml 3 DNA cleaved by A/wNI; lane 2: DNA size marker; lanes 3, 
5, and 7: unmodified (Co) or modified DNA (AAF or SePh) before 
incubation with B&I; lanes 4, 6, and 8: unmodified or modified 
Ml3 DNA incubated in the presence of BstBI. These reactions, 
performed at 65 “C, produced some non-specific nicking of 
double-stranded circular DNA. 
of the patch within the 37 base pair (bp) SmaI-Pstl 
segment of the substrate (see scheme in Fig. 4). 
During incubation with HeLa-cell extract, background 
DNA synthesis occurred randomly, presumably at strand 
breaks that are either preexisting or induced by non- 
specific nucleases [6]. As a consequence, reactions with 
unmodified Ml3 DNA produced incorporation of radio- 
labelled nucleotides into all three DNA fragments in pro- 
portion to their length (Fig. 5a, lane 1). When the 
AAF-modified DNA was incubated with cell extract, 
however, incorporation of radiolabelled nucleotides into 
the 37-bp SmaI-PrtI fragment was considerably enhanced 
(Fig. 5a; lanes 2 and 3, in duplicate). In contrast, when 
Ml3 DNA containing the site-directed selenophenyl 
adduct was incubated with HeLa-cell extract, no 
increased incorporation of radiolabel in the 37-bp frag- 
ment was visible (Fig. 5a; lanes 4-6, in triplicate). 
Densitometric analysis of three independent experiments 
demonstrated that the AAF adduct caused a -70-fold 
increase in the incorporation of radioactive nucleotides 
into the 37-bp fragment (Fig. 5b).When the site-specific 
selenophenyl and pivaloyl adducts were tested, nucleotide 
incorporation in the 37-bp tiagment was not significantly 
different from, that obtained in control reactions with 
unmodified substrate. 
The excision repair assay with selenophenyl-modified 
DNA was repeated using a different radiolabelled precur- 
sor, to ensure that deoxyribose adducts were not repaired 
by a distinct mechanism, such as base-excision repair, 
which produces much shorter patches of only one to 
three nucleotides [12]. In these experiments, [01-32P]dCTP 
was replaced by [a-““P]dATP because the selenophenyl 
group was situated on a deoxyribonucleoside with an 
adenine base. Incorporation of radiolabelled dAMP into 
the selenophenyl-containing, 37-bp fragment was again 
indistinguishable from background levels, excluding the 
possibility that alternative excision repair pathways for 
deoxyribose adducts exist. Additional control experiments 
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Fig. 4. Schematic representation of the DNA repair synthesis proto- 
col. Substrates containing a site-specific adduct were incubated 
with HeLa-cell extract, ATP, and all four deoxynucleoside triphos- 
phates, of which dCTP or dATP was radiolabelled. After 3 h at 
30 “C, DNA was recovered and digested with Avall, Smal, and 
PsH. This treatment produced a Smal-Psfl fragment of 37 bp, 
expected to contain the DNA repair patch, an Avall-Smal fragment 
of 330 bp located further 5’ to the 37-bp fragment, and a long frag- 
ment of 6920 bp. The hypothetical electrophoretic analysis illus- 
trates that damage-specific DNA repair synthesis induced by bulky 
adducts is confined to a region contained within the damaged 
37-bp fragment, as the human NER system has been shown to 
cleave DNA at the 22nd phosphodiester bond 5’ and the 6th 
phosphodiester bond 3’ to the lesion [5]. For comparison, the 
Smal-Psd fragment comprises 23 nucleotides 5’ and 13 nucleotides 
3’ to the AAF site. No difference in non-specific nucleotide incor- 
poration between damaged and undamaged control Ml 3 DNA is 
expected within the 330-bp and 6920-bp fragments. 
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Fig. 5. The deoxyribose adducts do not induce DNA repair synthesis. (a) Representative electrophoretic separation of DNA fragments 
visualized by autoradiography. (b) Densitometric quantification of radioactivity incorporated into the 37.bp fragment (mean values of 
three independent determinations + standard deviation) showing AAF-induced repair synthesis into the 37-bp fragment, and indicating 
that the selenophenyl- and pivaloyl-deoxyribose adducts are largely refractory to excision repair in vitro. DNA repair synthesis was 
expressed as fmol dCMP incorporated into the 37.bp fragment per 250 ng Ml 3 DNA. Co, unmodified Ml 3 DNA; AAF, Ml 3 DNA 
containing a site-specific AAF-guanine adduct; SePh, Ml 3 DNA with a site-specific selenophenyl-deoxyribose adduct; Piv, Ml 3 DNA 
containing a site-specific pivaloyl adduct. 
were performed in which we determined that DNA pattern, indicative of human NER, essentially no excision 
repair synthesis at AAF adducts was not affected by the products were released from DNA containing the site- 
presence of selenophenyl-modified DNA in the same directed selenophenyl (Fig. 7a; lanes 2 and 5, in duplicate) 
reaction mixture (data not shown), ruling out the possi- or pivaloyl adducts (lanes 3 and 6). Similarly, no excision 
bility that the modified DNA preparations contained a products were released from the control substrate con- 
non-specific repair inhibitor. taining no adducts (lane 4), although radioactive bands 
Dual DNA incision and oligonucleotide excision 
Mammalian NER is initiated by cleavage of the damaged 
strand on either side of the lesion, followed by excision of 
the lesion as the component of a single-stranded oligonu- 
cleotide segment of 29 residues in length [3-5].To measure 
this DNA incision and excision activity we used the in vitro 
assay devised by Huang et al. [5]. Site-specifically modified, 
duplex DNA substrates of 146 bp were constructed by lig- 
ating a 19-base oligonucleotide (19-mer) carrying the 
modification with five other oligonucleotides, as outlined 
in Figure 6. Prior to ligation, the central 19-mer was 
labelled with 32P-ATP at its 5’ end, such that the resulting 
146-bp substrate contained an internal label in the vicinity 
of the site-specific adduct.This radiolabel was located at the 
9th (pivaloyl), 11 th (selenophenyl), or 12th (AAF) phospho- 
diester bond 5’ to the site of modification (Fig. 6). The 
146-bp substrates were incubated with HeLa-cell extract in 
the presence ofATP and the four deoxynucleoside triphos- 
phates.After incubation for 45 min, reaction products were 
detected by denaturing polyacrylamide gel electrophoresis 
and autoradiography. 
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Repair reactions containing the AAF-modified substrate 
yielded excision products that had slightly lower electro- 
phoretic mobility than a 22-mer size marker (Fig. 7a; lane 
l).The formation of an oligonucleotide ladder instead of 
a single band was expected from previous studies and is 
due to partial degradation of the main 29-mer excision 
product in the cell-free extract [5]. Whereas AAF adducts 
were excised with this characteristic oligonucleotide 
Fig. 6. Schematic representation of the excision assay used in this 
study. (a) Internally labelled double-stranded fragments of 146 bp 
were assembled from 6 different oligonucleotides. The central 
19-mer contained the pivaloyl, AAF, or selenophenyl modification 
at position T9, Cl 1, or Al 2, respectively. Control substrate was 
assembled with unmodified 19-mers. Prior to ligation, the 19-mer 
was 5’ end-labelled with 32P-ATP, and the other five components 
(lengths in parentheses) were phosphorylated with nonradioactive 
ATP. (b) After ligation, the resulting substrate contained an inter- 
nal radiolabel near the site-specific modification. The arrow-heads 
indicate the expected major sites of cleavage by the human 
NER system. (c) Damage-specific dual incision generates radio- 
labelled products of 29 nucleotides in length. In the cell-free 
extract, these excision products are partially degraded yielding an 
oligonucleotide ladder upon electrophoretic separation [51. 
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Fig. 7. The deoxyribose adducts do 
not induce DNA excision. Internally 
labelled substrates containing a site- 
specific adduct were incubated with 
HeLa-ceil extract, ATP, and all four 
deoxynucleotides. After 45 min, DNA 
was recovered and analyzed on dena- 
turing polyacrylamide gels. (a) Auto- 
radiograph of the full-length gel with 
the excision products migrating near 
the 22.mer size marker. (b) Longer 
exposure of the bottom part of the gel. 
This autoradiograph was used for quan- 
tification of excision products by scan- 
ning densitometry. AAF, substrate 
containing the AAF adduct; SePh and 
Piv, substrates containing either a 
selenophenyl- or a pivaloyl-deoxyribose 
adduct; Co, unmodified substrate. 
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generated by non-specific nuclease activity were present at 
comparable levels at the top of the gel.The extent of exci- 
sion obtained in the reactions with AAF-, selenophenyl-, 
or pivaloyl-modified substrate was quantified by scanning 
densitometry of the area of the gel shown in Figure 7b. 
The corresponding region from the control substrate was 
taken as background (lane 4).This quantitative comparison 
indicated that oligonucleotide excision from seleno- 
phenyl- or pivaloyl-modified DNA was more than two 
orders of magnitude lower than that observed with 
AAF-modified DNA. 
Discussion 
NER is active on many DNA lesions that differ greatly in 
their conformation and chemical structure. In fact, this 
particular repair system processes not only cyclobutane 
pyrimidine dimers and pyrimidine(H)pyrimidone photo- 
products induced by UV light, but also DNA adducts 
caused by genotoxic chemicals [2-4,7]. The paradigm of 
NER in the prokaryote Eschevichiu coli shows that this 
pathway can process a broad variety of DNA adducts, 
including highly distortive and helix-destabilizing modifi- 
cations as well as modifications that stabilize the double- 
helix, such as those produced by the bulky antibiotic 
compound anthramycin (reviewed in [ 13,141). The 
hypersensitivity of NER-defective yeast [15] or human 
cells [16] to anthramycin suggests that the eukaryotic 
system possesses a similarly broad substrate range. Recent 
studies in vitro have confirmed that the human NER 
system recognizes a wide spectrum of DNA adducts, from 
bulky AAF-, psoralen-, or cisplatin-DNA adducts, to 
small base modifications such as 06-methylguanine or 
N6-methyladenine [8-l 01. 
To gain further insight into the damage recognition 
mechanism, we compared the activity of human NER on 
bulky adducts covalently bound either to a base (AAF) or 
a deoxyribose residue (selenophenyl, pivaloyl). We found 
that cleavage by BstBI was blocked by the presence of a 
single base modification or deoxyribose modification 
near the cleavage site (Fig. 3). An NER-proficient human 
cell extract, however, was unable to promote detectable 
levels of DNA repair synthesis in a 37-bp region contain- 
ing the selenophenyl or pivaloyl adduct (Fig. 5). The 
sequence environment examined was not generally 
refractory to NER, as demonstrated by the fact that the 
same cell extract induced DNA repair synthesis in 
response to the AAF adduct situated in the immediately 
adjacent nucleoside position. Mammalian NER is initi- 
ated by damage-specific incision 5’ and 3’ to the lesion, 
producing oligonucleotide segments of 29 residues in 
length that are excised from double-stranded DNA [3-51. 
As expected, we found that AAF adducts effectively stim- 
ulated the release of these excision products. In contrast, 
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the two deoxyribose adducts were essentially unable to 
induce oligonucleotide excision (Fig. 7). These studies, 
performed both at the level of DNA incision/excision 
and at the level of DNA repair synthesis, indicate that the 
selenophenyl- and pivaloyl-deoxyribose adducts are not 
efficiently repaired. Whether a selenophenyl or pivaloyl 
modification of DNA bases, rather than of the deoxy- 
ribose moiety, can be recognized by the NER system has 
not been tested.An NER response to such base adducts 
may be inferred, however, from the broad range of 
base modifications that are susceptible to human NER 
in vitro [lo]. 
Selenophenyl and pivaloyl substitutions are model sub- 
strates that do not exist in nature. Other completely syn- 
thetic DNA modifications have previously been tested 
and shown to constitute efficient substrates for the NER 
system. In one example, DNA containing a site-specific 
cholesterol moiety instead of a base was found to be one 
of the best substrates for the human NER system in vitro 
[17]. In other cases, DNA bases have been replaced by 
various organic derivatives that mimic the presence of 
apurinic or apyrimidinic sites. Such synthetic modifica- 
tions were also processed by prokaryotic [18] or human 
[lo] NER systems in vitro.The selenophenyl and pivaloyl 
adducts tested here are distinctly different from these pre- 
vious modifications because they involve formation of a 
deoxyribose adduct without replacing or affecting the 
adjacent base.The selenophenyl and pivaloyl substitutions 
decrease the melting temperature of duplex DNA (U.S., 
M.P. and B.G., unpublished data), indicating conforma- 
tional distortion of the helix.Thus, the low or abolished 
NER activity in response to these deoxyribose adducts 
suggests that covalent modification of DNA bases rather 
than structural alterations of the deoxyribose-phosphate 
backbone constitutes an important determinant for 
recognition by the human NER system. 
Significance 
Using site-specifically modified substrates we show 
that bulky deoxyribose adducts are processed very 
inefficiently by the human NER system in vitro. 
This finding contrasts with previous reports 
demonstrating that NER displays an extremely 
broad substrate range including virtually every 
form of base adduct [2-11,141. It therefore seems 
that the damage recognition system of NER is 
primarily sensitive to base lesions, suggesting that 
bulky substituents may escape this repair process if 
they are located on certain positions of the sugar 
moieties in the DNA backbone and do not change 
the chemistry of the bases. 
Several studies have established a correlation 
between the kinetics with which a particular lesion 
is removed from DNA in uiuo and the efficiency 
with which the same lesion is processed by the 
human NER system in vitro [19-211. In W-irradi- 
ated human cells, pyrimidine(64)pyrimidone 
photoproducts are eliminated with a consider- 
ably shorter half-life than cyclobutane pyrimi- 
dine dimers. A similar relationship was also 
reported to exist in vitro, where the former 
lesion is a more efficient substrate for the 
human NER system than the latter [19,20,22]. 
The absence of detectable excision repair in 
response to C4’ deoxyribose adducts in vitro may 
provide the conceptual basis for a new genera- 
tion of DNA substitutions that are highly refrac- 
tory to DNA-repair processes. DNA is the target 
for a number of clinically useful anticancer 
drugs, and many new DNA-reactive agents are 
being tested in clinical trials or developed for 
potential use as antineoplastic agents [23]. The 
efficacy of these chemotherapeutic agents prob- 
ably depends on the number and distribution of 
unrepaired DNA lesions in cancer cells [23,24]. 
Our approach, based on deoxyribose chemistry 
coupled to in vitro repair enzymology, may prove 
useful for the design of new and more effective 
chemotherapeutic strategies. 
Materials and methods 
Enzymes 
T4 polynucleotide kinase and T4 DNA ligase were purchased 
from Gibco BRL. Restriction enzymes were purchased from 
New England Biolabs. Creatine phosphokinase and ribo- 
nuclease A were from Boehringer Mannheim. All digestions 
with restriction enzymes were performed following the 
manufacturer’s instructions. 
Modified oligonucleotides 
The 19-mer 5’-ACCACCCTTCGAACCACAC-3’ was reac- 
ted with N-acetoxy-2-acetylaminofluorene (NC1 Chemical 
Carcinogen Repository, Rockville, Maryland) to form an AAF 
adduct at the single guanine (Gil) residue [6]. An oligo- 
nucleotide with the same sequence but containing a 
selenophenyl-deoxyribose adduct at position Al2 or a pival- 
oyl-deoxyribose adduct at position T9 was synthesized by the 
cyanoethyl phosphoramidite method using appropriate build- 
ing blocks, as described [25].The oligonucleotides were phos- 
phorylated by incubation with ATP and T4 polynucleotide 
kinase [26]. 
Construction of closed circular DNA containing a single 
modification at a specific position 
To produce site-specifically modified MlS-DNA molecules we 
first synthesized a gapped circular intermediate consisting of a 
circular (+)-strand and a linear (-)-strand (Fig. 2).This gapped 
intermediate contains a single-stranded region of 19 nucleotides 
that is complementary to the 19-mer described above. The 
synthetic DNA duplex: 
5'-GGTGTGGTTCGAAGGGTGGT-3' 
3'-ACGTCCACACCAAGCTTCCCACCAGATC-5' 
was ligated into the PstI-XbaI site of M13mp19 double- 
stranded DNA. This ligation generates an Ml 3-DNA deriva- 
tive, designated M13mp19G, which was used to transform the 
E. coli strain DH5olF’ (Gibco BRL). The resulting single- 
stranded DNA [27] provides the (+)-strand of the gapped 
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intermediateThe complementary (-)-strand was obtained by 
ligation of the duplex DNA: 
5'-GACGTCGATATCGTGCA-3' 
3'-ACGTCTGCAGCTATAGCACGTGATC-5' 
into M13mp19 double-stranded DNA digested with PstI and 
XbaI, generating a second M13-DNA derivative designated 
M13mp19Hb5. The insert in this DNA molecule contains the 
restriction sites for AatII (5’-GACGT’C-3’) and ApaL 
(5’-G’TGCAC-3’). After amplification in the strain DH5aF’, 
M13mp19Hb5 DNA was purified by CsCl gradient centrifuga- 
tion [26] and linearized by digestion with AatII and ApaLI.The 
obtained large fragment was then separated by gel-filtration chro- 
matography on a Bio-Gel P-100 column (Bio-Rad). 
M13mp19G single-stranded DNA (typically 1.2 mg) and the 
large fragment of M13mp19Hb5 (200 p,g) were coincubated 
3 min at 95 “C (denaturation), followed by 15 min at 65 “C and 
2 h at room temperature (hybridization), in a volume of 1.3 ml 
containing 60 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 
10 n&I EDTA (Fig. 2). The resulting gapped circular DNA 
(-100 kg) was purified by chromatography through benzoylated 
naphthoylated DEAE cellulose (Sigma) and ethanol precipitation 
as described [28]. Modified 19-mers containing an AAE 
selenophenyl, or pivaloyl adduct were ligated into the gapped 
M13-DNA intermediate in 0.2~ml reactions containing 30 kg of 
Ml3 DNA, 1.0 Fg of phosphorylated oligonucleotides, and 10 U 
ofT4 DNA ligase in 50 mM Tris HCl, pH 7.6, 10 mM MgCl,, 
1 mM ATP, 1 mM dithiothreitol, and 5 % (w/v) polyethylene 
glycol 8000. After incubation for 4 h at 16 “C, covalently closed 
duplex DNA was purified by CsCl gradient centrifugation. In a 
typical preparation, we obtained about 10 p.g of purified final 
products. Control Ml3 DNA substrates were constructed by 
ligating unmodified 19-mers into the gapped DNA. 
Assay for DNA repair synthesis 
HeLa-cell extracts were prepared by the method of Manley et al. 
[29]. Repair reactions (50 p,l) were slightly modified from 
Hansson et al. [6] and contained HeLa-cell extract (80 p,g of pro- 
teins), 250 ng of modified or unmodified Ml3 DNA, 45 mM 
HEPES, pH 7.8, 70 mM KCl, 7.4 mM MgCl,, 0.9 mM dithio- 
threitol, 0.4 n&I EDTA, 3.4 % glycerol, 2 mM ATP 20 FM each 
of dATP dGTP, and dTTP, 8 FM dCTP, 2.0 pCi [a-32P]dCTP 
(3000 Ci/mmol; DuPont NEN), 40 mM phosphocreatine, 2.5 p,g 
creatine phosphokinase, and 18 kg bovine serum albumin. 
Alternatively, incubations were performed in the presence of 
8 pM dATP and [a-32P]dATP After 3 h at 30 “C, reactions were 
stopped by the addition of EDTA to 20 mM.The samples were 
incubated at 37 “C with ribonuclease A (80 p,g ml-‘) for 10 min. 
SDS (to 0.5 %) and proteinase K (to 190 pg ml-‘) were then 
added, and the mixtures incubated for a further 45 min at 37 “C. 
DNA was extracted, digested with AvuII, SmuI, and &I, and ana- 
lyzed by 20 % polyacrylamide gel electrophoresis and autoradio- 
graphy This enzymatic digestion produced a SmuI-PstI fragment 
of 37 bp encompassing the site of modification. DNA repair syn- 
thesis was quantified by scanning densitometry of the X-ray films 
on a Molecular Dynamics Computing Densitometer using 
ImageQuant software. The densitometry was calibrated with 
radioactive bands that were excised from the dried gel and quanti- 
fied by Cerenkov counting. DNA repair synthesis in the 37-bp 
SmuI-PstI fragment was expressed as fmol of nucleotides per 
reaction containing 250 ng of Ml3 DNA. 
Linear DNA substrates 
Internally radiolabelled DNA duplexes of 146 bp were obtained 
by ligating the 19-mer (5’-ACCACCCTTCGAACCACAC-3’) 
with 5 other partially overlapping oligonucleotides (Fig. 6) as 
previously described [30]. Briefly, the 19-mer (150 pmol) was 
labelled with [Y-“~]ATP (7000 Ci/mmol; ICN Pharmaceuticals, 
Inc.) and mixed with 200 pmol each of the other five oligo- 
nucleotides, which were phosphorylated with nonradioactive 
ATPThe mixture was annealed in 40-1.r.1 reactions containing 
50 mM Tris HCl, pH 7.9, 100 mM NaCl, 1 mM dithiothreitol, 
and 10 mM MgCl,. After heating to 85 “C for 2 min, samples 
were cooled gradually by incubation at room temperature for 
4 h. Ligation was then carried out for 18 h at 16 “C in the pres- 
ence of 1 mM ATP, 5 U of T4 DNA ligase, and 50 p,g ml-’ 
bovine serum albumin.The full-length fragment of 146 bp was 
isolated by electrophoresis in a preparative 6 % polyacrylamide 
gel under denaturing conditions [26]. Purified DNA was resus- 
pended in 50 ~1 of 50 mM Tris HCl, pH 7.9, 100 mM NaCl, 
and 10 mM MgCl,, reannealed, and subjected to a second round 
of purification by 6 % native polyacrylamide gel electrophoresis 
before incubations with cell extract. 
Excision assay 
Excision reactions were performed as described [5,10] and con- 
tained (in 25 ~1) 35 mM Hepes-KOH, pH 7.9, 60 mM KCl, 
40 mM NaCl, 5.6 mM MgCl,, 2 mM ATP, 20 FM each of 
dATP, dCTP, dGTP and dTTP 0.8 n&l dithiothreitol, 0.4 mM 
EDTA, 3.4 % (V/V) glycerol, 5 p.g bovine serum albumin, 
5 fmol radiolabelled DNA substrate, and 50 pg HeLa cell-free 
extract. Incubations were carried out at 30 “C for 45 min, and 
were stopped by the addition of SDS to 0.3 % (w/v) and pro- 
teinase K to 0.2 mg ml-‘. After proteinase K digestion (15 min 
at 37 “C) and phenol/chloroform extraction, DNA was 
resolved by electrophoresis in 15 % poylacrylamide denaturing 
gels and excision products were visualized by autoradiography. 
The level of excision was quantified by scanning densito- 
metry of the X-ray films (Molecular Dynamics Computing 
Densitometer with ImageQuant sofhvare). 
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